Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis
- PMID: 21887729
- DOI: 10.1002/ibd.21845
Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis
Abstract
Background: Inflammatory bowel diseases (IBD) result from an interaction between genetic and environmental factors. Preliminary findings suggest that susceptibility genes differ between IBD patients in Asia and the West. We aimed to evaluate disease-predisposing genes in Asian IBD patients.
Methods: A systematic review and meta-analysis were performed of published studies from 1950 to 2010 using keyword searches in MEDLINE, EMBASE, EBM Reviews, and BIOSIS Previews.
Results: In all, 477 abstracts were identified and data extracted from 93 studies, comprising 17,976 IBD patients and 27,350 age- and sex-matched controls. Major nucleotide oligomerization domain (NOD)-2 variants in Western Crohn's disease (CD) patients were not associated with CD in Han Chinese, Japanese, South Korean, Indian, and Malaysian populations. New NOD2 mutations were, however, associated with CD in Malaysians (JW1), Han Chinese, and Indians (P268S). Autophagy-related protein 16-linked 1 (ATG16L1) was not associated with CD in East Asians (odds ratio [OR] 0.97; 95% confidence interval [CI] 0.84-1.13). Interleukin (IL)-23R was associated with CD in South Koreans (OR 1.8; 95% CI 1.16-2.82) and a single nucleotide polymorphism in IL-23R (Gly149Arg) was protective of CD in Han Chinese (OR 0.3; 95% CI 0.15-0.60). Tumor necrosis factor (TNF) superfamily gene-15 (SF15) polymorphisms were associated with CD (OR 2.68; 95% CI 1.86-3.86), while TNF-308 polymorphisms (OR 1.82; 95% CI 1.15-2.9), cytotoxic T lymphocyte antigen (CTLA)-4 (OR 2.75; 95% CI 1.22-6.22) and MICA allele (OR 2.41; 95% CI 1.89-3.07) were associated with ulcerative colitis in Asians.
Conclusions: Genetic mutations of IBD in Asians differ from Caucasians. New mutations and susceptibility genes identified in Asian IBD patients provide an opportunity to explore new disease-associated mechanisms in this population of rising incidence.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.
Similar articles
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
Vitamin D for the treatment of inflammatory bowel disease.Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2. Cochrane Database Syst Rev. 2023. PMID: 37781953 Free PMC article.
-
Association of STAT4 rs7574865 polymorphism with susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):627-36. doi: 10.1016/j.clinre.2015.04.002. Epub 2015 Jun 9. Clin Res Hepatol Gastroenterol. 2015. PMID: 26066297
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Patient education interventions for the management of inflammatory bowel disease.Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2. Cochrane Database Syst Rev. 2023. PMID: 37172140 Free PMC article.
Cited by
-
Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases.Autophagy. 2012 Sep;8(9):1286-99. doi: 10.4161/auto.21212. Epub 2012 Aug 14. Autophagy. 2012. PMID: 22878595 Free PMC article. Review.
-
Relating the transcriptome and microbiome by paired terminal ileal Crohn disease.iScience. 2021 May 5;24(6):102516. doi: 10.1016/j.isci.2021.102516. eCollection 2021 Jun 25. iScience. 2021. PMID: 34113837 Free PMC article.
-
Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients.Cells. 2019 May 1;8(5):404. doi: 10.3390/cells8050404. Cells. 2019. PMID: 31052430 Free PMC article. Review.
-
Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn's Disease: A Hospital-Based Cohort Study.Dig Dis Sci. 2016 Jul;61(7):2060-7. doi: 10.1007/s10620-016-4105-6. Epub 2016 Mar 12. Dig Dis Sci. 2016. PMID: 26971089
-
Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study.Intest Res. 2021 Jan;19(1):83-94. doi: 10.5217/ir.2019.09160. Epub 2020 Dec 31. Intest Res. 2021. PMID: 33378612 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources